Aetna BALANCE Model GLP-1 Coverage: What Aetna Members Actually Get in 2026

Disclosure: Some links on this page are affiliate links. If you start care through one, The RX Index may earn a commission at no extra cost to you. It does not change any of the CMS, Medicare, Medicaid, or Aetna coverage information below. We earn nothing from the federal program most readers of this page should use first.

---

The Aetna BALANCE Model GLP-1 answer is simpler than the headlines make it sound. BALANCE is a federal CMS program, not an Aetna benefit — and its Medicare piece is not launching in 2027. Eligible Aetna Part D members instead use a separate program, the Medicare GLP-1 Bridge, to get certain weight-loss drugs for $50 a month. Aetna Medicaid and Aetna work plans follow completely different rules.

Here's the part the plan name hides: Aetna cannot approve that $50 request. Aetna doesn't run it, doesn't pay for it, and doesn't decide it. That sounds like bad news. It isn't. It means your Aetna plan's decision about BALANCE cannot keep an otherwise eligible member out of the Bridge.

What can lock you out is why the drug was prescribed, a GLP-1 claim that Part D already paid in 2026, and — this catches people — the order your pharmacy and your doctor do things in. Get that order backwards and the computer sends back an error that looks like a denial but isn't one.

We'll show you exactly which lane you're in, and exactly what to do next.

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

---

Is this page for you?

Yes, if:

• You have Aetna Medicare Advantage, SilverScript, an Aetna SNP or D-SNP, Aetna Better Health, or Aetna through work
• You saw something about BALANCE or a $50 GLP-1 program and can't tell if it applies to you
• Your pharmacy or doctor sent the request somewhere and it bounced back
• You're not sure which form of your drug qualifies

No, if:

• You want medical advice on which GLP-1 is right for your body — that's a conversation with your doctor
• You don't have Aetna and just want the general rules → see our Medicare GLP-1 Bridge eligibility guide
• You're comparing compounded telehealth providers — this page is about FDA-approved medicine and federal programs, and we keep those separate on purpose

---

Start here: the 10-second sort

Four different systems. One insurance card. That's the whole confusion in one table.

---

Is the Aetna BALANCE Model GLP-1 program an Aetna benefit?

No. BALANCE is a voluntary CMS program, not something Aetna created or sells. CMS says the Medicare part of BALANCE will not launch in 2027. A separate federal program called the Medicare GLP-1 Bridge is running now, from July 1, 2026 through December 31, 2027, and it covers certain weight-loss drugs at a $50 monthly copay.

Let's clear up the name first, because it trips people up.

BALANCE stands for Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth. CMS — the federal agency that runs Medicare and Medicaid — announced it on December 23, 2025. The idea: CMS negotiates drug prices and coverage terms with manufacturers, then eligible state Medicaid agencies and, in any future Medicare version, Part D sponsors can choose to use them.

That word "choose" is the whole story.

What happened to Medicare BALANCE

CMS did not launch BALANCE in Medicare for 2027. It extended the separate Medicare GLP-1 Bridge through the end of 2027 instead, saying the extra time would let it collect GLP-1 use data before any potential future BALANCE rollout in Part D.

So if you've been feeling like you picked the wrong insurance company: you didn't. No Medicare plan is in BALANCE for 2027. Not Aetna. Not UnitedHealthcare. Not Humana. CMS's own BALANCE page still lists the model stage as "Announced" and the number of participants as "N/A."

BALANCE and the Bridge are not the same thing

People mix these up constantly. Two different programs, two different rulebooks.

The takeaway: BALANCE is the program that didn't happen for Medicare in 2027. The Bridge is the one that did. When someone means the new federal $50 weight-loss access, they mean the Bridge.

The one thing Aetna is honest about

Aetna's own Medicare page says plainly that the Bridge is a CMS program and that Aetna does not approve Bridge prior authorization requests.

That's not Aetna dodging. It's accurate. And it explains something frustrating a lot of people hit: you call the number on your Aetna card, ask about the $50 program, and the person can't approve it. They're not being difficult. It genuinely isn't theirs to decide.

Where to call instead: 1-800-MEDICARE (1-800-633-4227). CMS has told plans to send Bridge questions there. TTY users: 1-877-486-2048.

---

What changed for Aetna Medicare members in 2026?

Since July 1, 2026, eligible Aetna Part D members have been able to get certain weight-management GLP-1 drugs for a $50 monthly copay through the Medicare GLP-1 Bridge. Aetna does not opt in, does not set the rules, and does not approve the request. The program runs through December 31, 2027.

Federal law excludes drugs when they are used for weight loss from the normal Part D benefit. That rule hasn't changed. What changed is that CMS built a time-limited demonstration that sits outside the Part D coverage and payment flow — so it doesn't need your plan's permission.

Three things follow from that:

1. Your plan carries no risk and gets no say on Bridge approval. CMS put it in writing to insurance companies in a June 10, 2026 memo: "Part D plan sponsors are not participants in the Medicare GLP-1 Bridge." Not "declined to participate." Not participants. Your Part D plan has no Bridge-approval seat at the table.

2. The government negotiated the net price down to $245. Drugmakers agreed to supply Bridge drugs at a net price of $245 for a monthly supply. You pay $50 of that.

3. It has an end date, and you should plan around it. December 31, 2027. Not a marketing deadline — a real one, written into the program.

The $50 is not an Aetna price

Worth saying clearly: the $50 is the copay for one monthly supply of one eligible drug through the Bridge. It is not an Aetna copay. It is not a discount on your Part D drugs. And it doesn't apply to every GLP-1 — the list is short and specific.

### ▶ Not sure which path to check first? Use Find My GLP-1 Path for a personalized starting point based on your insurance, state, preferred form, and budget. It does not replace the Bridge rules below, but it can help you see which path deserves your next call. → Find my GLP-1 path — free, personalized in about 2 minutes

---

Which Aetna GLP-1 coverage lane applies to me?

The word "Aetna" on your card cannot answer the coverage question by itself. Five things decide it: your plan type, the drug and its exact form, why it was prescribed, your BMI when GLP-1 therapy began, and whether Part D already paid for a GLP-1 in 2026. Those five facts sort you into one of four systems.

This table is the heart of the page. We built it by pulling rules CMS and Aetna publish in six different places and lining them up. No single official page puts them together, because each one is written for a different audience — one for pharmacies, one for prescribers, one for insurance companies, one for members.

The Aetna GLP-1 Coverage Lane Matrix

How we built this: we compared CMS's current BALANCE guidance, CMS's Bridge guidance written for members, prescribers, pharmacies and insurance plans, the Bridge prior authorization form, Aetna's public Medicare Bridge page, Aetna's Medicare drug-list guidance, and Aetna's employer coverage guidance. "Your lane" is our editorial read of those rules. It is not an approval and not a medical decision.

A note on SilverScript

If your card says SilverScript, you're still in the Aetna family — SilverScript is Aetna's standalone Medicare drug plan. That's a qualifying plan type for the Bridge. But the plan type is just the first gate.

If you have an SNP or D-SNP

Special Needs Plans count too, including plans for people who have both Medicare and Medicaid. Same rule: the plan type opens the door, the clinical rules decide whether you walk through it.

---

Do I qualify for the $50 Medicare GLP-1 Bridge with Aetna?

You need four main things: a qualifying Medicare drug plan, a prescription written for weight management, one of three specific drugs in the right form, and one of three BMI-and-condition combinations. You must also be at least 18, use the drug with current and ongoing nutrition and physical-activity changes, and have no disqualifying 2026 Part D GLP-1 fill. Meeting the BMI number alone is not enough. And if your prescription belongs in regular Part D, you cannot use the Bridge instead — even if the drug isn't on your plan's list.

Four main gates, plus one claims-history stop. You have to clear all of them.

Before the four gates, your prescriber must attest that you are at least 18 and that treatment includes current and ongoing lifestyle changes, including structured nutrition and physical activity as appropriate.

Gate 1 — A qualifying Medicare drug plan

An excluded plan type does not qualify by itself. CMS says a person may still qualify through a separate qualifying standalone Part D plan when that combination is allowed.

The program is nationwide, including all U.S. territories.

Gate 2 — The prescription has to be for weight

This is the gate that surprises people most.

If the prescription is for type 2 diabetes, moderate-to-severe sleep apnea, or noncirrhotic MASH with moderate-to-advanced liver scarring, it goes through your Aetna Part D plan. Not the Bridge. A prescription written to reduce the risk of a heart attack, stroke, or another major cardiovascular event in someone with established cardiovascular disease also goes through Part D.

CMS tells the prescriber to use clinical judgment about whether one of those diagnoses still applies. A condition being controlled by treatment does not automatically mean it is gone.

Here's the trap, stated repeatedly in CMS guidance to insurance companies: for a Medicare-coverable use, that is true regardless of whether the drug is on your Aetna plan's list.

Read that again if you need to. Most people assume: not on my formulary → not covered → so I'll use the Bridge. Wrong. For type 2 diabetes, sleep apnea, and MASH, having the diagnosis closes the Bridge door, even if Aetna does not cover that drug for the condition. Your fix is an Aetna coverage determination, appeal, or formulary exception — not the Bridge.

Heart disease is different. Established cardiovascular disease alone does not close the Bridge door. The purpose of the prescription does. If the drug is prescribed for weight management, the Bridge may still apply. If it is prescribed to reduce major cardiovascular events, it belongs in Part D — even if weight management is also one reason for treatment.

One more thing, and we mean it: do not change how your diagnosis or the purpose of the prescription is described to get the cheaper price. Your prescriber signs the Bridge form under penalty of perjury. It's not worth it, and it's not necessary — the Part D lane has real options, covered below.

Gate 3 — The right drug, in the right form

The Bridge covers exactly three brands:

• Foundayo (orforglipron) — all current formulations, which are tablets
• Wegovy (semaglutide) — all formulations, including injections and tablets
• Zepbound (tirzepatide) — KwikPen only

Not Ozempic. Not Mounjaro. Not Rybelsus. And not every Zepbound.

⚠️ The Zepbound form trap

Zepbound single-dose vials and single-dose pens are not covered by the Bridge. Only the KwikPen is.

Same active ingredient. Same company. Different device — and the Bridge claim gets rejected. If your doctor is writing for Zepbound, the word KwikPen has to be on the prescription. Ask.

Gate 4 — One of three BMI paths

The detail the main CMS table hides: if your BMI is between 30 and 34.9, you actually have seven possible qualifying conditions, not three. A BMI of 30 also clears the 27-or-higher bar, so both lists apply to you.

We're pointing it out because a person at BMI 32 can read "heart failure, blood pressure, kidney disease," not see themselves, and stop. If you have prediabetes already documented in your chart, you may qualify at BMI 30 and never knew it.

What "uncontrolled" blood pressure means here: CMS defines it precisely on the form. Blood pressure above 140 on top or 90 on the bottom, despite taking two blood pressure medicines at the same time. High readings alone don't count. You need the two-medicine part.

Claims-history stop — Part D cannot already have paid in 2026

Even if you clear the four gates above, you are not eligible for the Bridge in 2026 if Part D already paid for Zepbound, Mounjaro, Foundayo, Rybelsus, Ozempic, Wegovy, Saxenda, Victoza, or Trulicity during 2026. That includes a fill paid through supplemental employer or union Part D coverage. The exact rule and what to check are covered below.

Starting BMI, not today's BMI

This one causes real arguments in exam rooms.

CMS uses your BMI at the time GLP-1 therapy began. If you were already taking a GLP-1 before the Bridge, use the documented BMI from when that therapy started. If you have not started GLP-1 therapy, use the BMI at the time you begin it. An older untreated high weight does not count as the initiation BMI.

One reader in an r/medicare thread put the problem exactly right: "My doctor insists she has to use my current BMI."

If the clinician means your current BMI after GLP-1 therapy already started, the CMS form says otherwise. But the instruction sits on a form written for prescribers. If you've already lost weight on treatment, bring documentation of the BMI from when therapy began.

### ▶ Give your doctor the right facts the first time Requests can fail because information is missing, the wrong BMI date is used, or the wrong form of the drug is prescribed. The full guide walks through the 12 questions on the CMS form, the initiation-BMI rule, and the exact drug wording your prescriber needs. → Open the Medicare GLP-1 Bridge eligibility checklist

---

Which GLP-1 drugs does each program cover?

The three drug lists are not the same. The Bridge covers Foundayo and Wegovy formulations, plus Zepbound KwikPen only. The BALANCE model list is broader and includes Ozempic, Mounjaro, and Rybelsus. Regular Aetna Part D coverage depends on your exact plan, the formulary, and why the drug was prescribed.

Put them side by side and the confusion disappears.

Why Ozempic isn't a Bridge drug

Ozempic is not FDA-approved for chronic weight management. The Bridge only pays for drugs on its list when they are prescribed for weight management. So Ozempic falls outside it — but it may be covered by your regular Aetna Part D plan for an approved, Medicare-coverable use such as type 2 diabetes.

Same molecule as Wegovy. Different approval. Different lane. That's how the whole system works.

A word on compounded medication

Compounded GLP-1s are not part of the Bridge, not part of BALANCE, and not the same thing as an FDA-approved brand. We don't treat them as interchangeable, and neither does the FDA. Compounded drugs are made under different federal rules and do not go through FDA premarket review for safety, effectiveness, or quality.

Compounding can meet a real patient need when an FDA-approved drug cannot meet it. A Medicare member who qualifies for the $50 Bridge already has an FDA-approved covered route. We're not going to point you past it to a compounded product.

One drug-list detail worth knowing

For a drug to even be considered for BALANCE, CMS required it to reduce body weight by at least 9.5% on average at an FDA-approved dose, based on a main or secondary result in a randomized clinical trial. That's the bar. It's why the list is short.

---

How do I get the request processed without a "patient not found" error?

The pharmacy claim has to come before the prior authorization. Your doctor sends the prescription to the pharmacy, the pharmacy submits a claim to the Bridge system, and that claim creates the record the authorization attaches to. If your prescriber files the paperwork first, the system returns "patient not found" — which looks like a denial but isn't one.

If you only read one section, make it this one. This is where a request can get stuck, and the fix is the order.

The five steps, in order

Step 1 — Your doctor sends the prescription to your pharmacy. Not to Aetna. Not to Medicare. To the pharmacy. And it has to name the exact brand and form — including the word KwikPen if it's Zepbound.

Step 2 — Your pharmacy submits the claim to the Bridge, not to Aetna. The Bridge has its own billing information. Your pharmacist needs your Medicare Number, also called the Medicare Beneficiary Identifier or MBI, plus two routing numbers:

BIN 028918 · PCN MEDDGLP1BR

You do not need an Aetna denial first. That's a common myth. A properly addressed Bridge claim can go straight in.

Step 3 — For a potentially eligible claim, the system responds that prior authorization is needed. This rejection is supposed to happen. It's part of the process, not the end of it. Don't panic when the pharmacist says "it came back rejected."

Step 4 — The pharmacy sends the authorization request to your prescriber. Usually electronically or by fax, typically within 24 to 72 hours.

Step 5 — Your prescriber submits the Bridge authorization. Twelve questions. Your BMI at the start of GLP-1 therapy and the purpose of the prescription have to be filled in correctly. Only a prescribing clinician can submit it — you can't do this part yourself.

CMS says the approval or denial is mailed to you and sent to the prescriber within 72 hours after the completed prior authorization is submitted.

If nothing reaches your doctor within 72 hours after the pharmacy claim, your prescriber can use CMS's published fax form directly rather than waiting. The fax number printed on the form is 1-800-530-2404. Prescribers can also call the Bridge help line at 1-855-273-0102, Monday through Friday, 8 a.m. to 7 p.m. Eastern.

Say this at the pharmacy counter

Bring your Medicare card. Copy this. Read it out loud. It names the exact routing facts.

"Can you check whether this should go to the Medicare GLP-1 Bridge instead of my regular Aetna plan? I have my Medicare card. The BIN is 028918 and the PCN is MEDDGLP1BR. The Bridge pharmacy claim has to be submitted before my doctor can send the prior authorization."

If the counter staff doesn't recognize it, ask for the pharmacy manager. The pharmacy can call the Bridge Pharmacy Help Desk at 1-844-673-0910.

What Aetna may send back to help

CMS asked plans to be helpful here. When a pharmacy accidentally bills Aetna for a weight-loss GLP-1, CMS "strongly encourages" plans to return a message reading "FOR OBESITY: BIN 028918 PCN MEDDGLP1BR" — essentially a forwarding address.

Note the wording: encouraged, not required. So the pointer may or may not appear. Don't count on it. Ask for the Bridge by name up front.

What real people are running into

From public discussion threads on r/medicare in the weeks after launch:

"What should I ask?"

"Did your pharmacy or doctor know how to process it?"

Those are the two questions, over and over. The friction isn't proof that someone qualifies or that a claim will be approved. It shows why the routing order and the exact words matter.

(These are reader comments showing where confusion happens. They are not evidence about eligibility, approval rates, or medical outcomes.)

### ▶ Walk in with the exact words Save the script above, then open the full guide before your doctor or pharmacy sends the request. It puts the drug list, BMI rules, form questions, and pharmacy-first order in one place. → Open the pharmacy-first Bridge guide

---

What does Aetna still have to cover?

The Bridge did not reduce Aetna's own obligations. In a June 10, 2026 memo to Medicare drug plans, CMS said sponsors must keep covering GLP-1s for Medicare-covered uses at the level they bid for 2026, must keep running their exception process, and — this is the important one — must not deny or limit access in a way that pushes members onto the Bridge.

The rule sits in a memo written for insurance companies, not on the member page most people see.

Here's what the memo says Aetna must do, may do, and must not do:

Why this matters to you personally

Suppose you have moderate-to-severe sleep apnea. Zepbound is FDA-approved for that. Your Aetna plan denies it and someone suggests you "just use the $50 program."

That is exactly the behavior CMS said it is watching for.

The memo says CMS will conduct rigorous monitoring to make sure plans aren't shifting members onto the Bridge, and that it can act under 42 CFR 423.752 — the rule that lets CMS impose sanctions on Medicare plans that don't meet their obligations.

You don't need to be a lawyer to use this. If Aetna denies a GLP-1 for a Medicare-coverable use and steers you toward the Bridge, you can say: "My understanding is that CMS's June 10, 2026 guidance says plans can't limit access in a way that encourages Bridge use. I'd like this reviewed."

Write down the date, the representative's name, and your reference number. That sentence changes the tone of the call.

Also worth knowing

Your Part D appeal rights didn't change at all. And Aetna isn't responsible for handling Bridge decisions. Member questions go to 1-800-MEDICARE; prescribers and pharmacies use the Bridge help desks. So if you're stuck on a Bridge issue, calling Aetna repeatedly won't help no matter how patient you are. It's not their system.

---

What if I already filled a GLP-1 through Part D in 2026?

CMS checks your 2026 Part D claims history. If Part D already paid for Zepbound, Mounjaro, Foundayo, Rybelsus, Ozempic, Wegovy, Saxenda, Victoza, or Trulicity at any point during 2026, you are not eligible for Bridge coverage in 2026 — including when that earlier coverage came through a supplemental employer or union Medicare plan.

This one catches people who were doing everything right.

The Bridge was built for people who are using an eligible GLP-1 for weight management outside normal Part D coverage. If Part D already paid for one of the listed GLP-1s this year, CMS's rule is simple: stay in the Part D lane for 2026.

What to check before you get your hopes up

• Your Part D Explanation of Benefits statements for 2026
• Your pharmacy's printed claims history
• Your Aetna member portal
• Your doctor's prior authorization records

If you filled Ozempic for diabetes in February and now want Wegovy for weight in September, that February Part D fill makes you ineligible for the Bridge in 2026.

About 2027: CMS had not finalized the 2027 lookback period as of our August 14, 2026 verification. Anyone telling you they know the final 2027 rule is guessing. We'll update this page when CMS publishes it.

---

What if Aetna or the Bridge says no?

Before you appeal anything, figure out who actually said no and why. A pharmacy routing error, a BMI or form-data error, the wrong drug form, a Bridge eligibility denial, an Aetna Part D denial, and an employer-plan exclusion are six different problems with six different fixes. Treating all of them as "Aetna denied my GLP-1" sends you down the wrong path.

Work through these in order. Start with #1.

1. It went to Aetna but should have gone to the Bridge. Go back to the pharmacy-first steps above. Give the pharmacy your Medicare Number, the BIN, and the PCN.

2. The wrong BMI number was used. Your prescriber used today's BMI even though GLP-1 therapy started earlier. Get documentation of the BMI at therapy initiation and resubmit. If you have not started therapy, an older high weight is not the initiation BMI.

3. The wrong form was prescribed. Zepbound vial or single-dose pen instead of KwikPen. New prescription, correct device.

4. Your prescription belongs in Part D. You have type 2 diabetes, moderate-to-severe sleep apnea, noncirrhotic MASH with moderate-to-advanced fibrosis, or the drug is being prescribed to reduce major cardiovascular events. This isn't a Bridge problem. Check the Aetna Medicare drug list, then use Aetna's coverage decision, exception, or appeal process — and remember the anti-shifting rule if Aetna pushes you toward the Bridge.

5. The Bridge authorization itself was denied. There's no formal appeal process for a Bridge decision. But your prescriber can resubmit if information was wrong or if there's updated or additional information — a corrected initiation BMI, a diagnosis that was on file but not included, or a qualifying condition that was missed. Resubmitting is the path.

(This is different from regular Part D. Part D denials come with appeal and exception rights, and those haven't changed.)

6. Your job-based plan excludes weight-loss drugs entirely. Employers choose this. If yours excluded it, an ordinary drug appeal cannot add a benefit the employer did not buy. Talk to HR about whether the plan can add it at renewal.

---

What if none of these lanes work for you?

Some people won't fit the Bridge: BMI below 27, no qualifying condition, the wrong drug form, or a Part D GLP-1 fill in 2026. Other people have a job plan that excludes weight-loss coverage. Before you pay cash, check every path in this order — and only the fourth one may earn us anything. We'll tell you which.

Here's the honest order to check them.

We put our own revenue fourth on purpose. If options 1 through 3 are open to you, check them before you pay for a telehealth membership. Come back later for help comparing something else.

But if the Bridge rules disqualify you and no Part D or manufacturer cash path works, you have a real problem that needs a real prescription — not another loop through the wrong system.

The honest limitation

Ro is not the Medicare GLP-1 Bridge processor. Humana handles Bridge prior authorizations and claims for CMS. Ro's terms say its services and products are cash pay outside federal and state health programs. Do not start a membership expecting Ro to process or pay a Bridge claim. Ro also can't make Aetna say yes.

Its free insurance checker covers the Ozempic pen, Wegovy pen, and Zepbound pen. It does not check insurance coverage for Zepbound KwikPen, Foundayo pill, or Wegovy pill. If you need the Bridge, your current prescriber and pharmacy are the better place to start.

But if what you need is a cash-pay prescription for an FDA-approved brand and a clinician says it is appropriate, that gap is exactly why Ro can be useful. It does not turn an Aetna denial into insurance coverage. It gives you an online clinician and a cash-pay path outside Medicare. Ro currently lists Zepbound KwikPen, Foundayo pill, and Wegovy pill and pen among its options.

Pricing: The Ro Body membership is $39 for the first month, then as low as $74 per month with an annual plan paid upfront. The ongoing monthly plan is $149 per month. Medication cost is separate. The membership renews automatically unless you cancel at least 48 hours before the next renewal date.

### ▶ If the federal and insurance paths are closed to you Does that sound like your situation? Check which FDA-approved GLP-1 options Ro currently offers and whether a Ro-affiliated clinician considers one appropriate for you. → Check your eligibility on Ro (affiliate link)

One thing we won't do: send a Medicare member past an available FDA-approved federal route to a compounded GLP-1 program from this page. Compounded medication is not FDA-approved, it isn't part of the Bridge or BALANCE, and blurring that line on a page about Medicare coverage would be doing you a disservice.

---

Does the BALANCE Model apply to Aetna Better Health (Medicaid)?

Maybe — but there is no national "Aetna participates" answer for Medicaid. Each state Medicaid agency decides whether to join BALANCE. Coverage, timing, prior authorization rules, and cost all have to be checked for your specific state and your Aetna Better Health plan.

This is where BALANCE is still moving. The Medicare piece did not launch for 2027. The Medicaid piece kept going.

Why your state matters more than the Aetna name

Aetna Better Health runs Medicaid plans in a number of states under contract with each state government. The state sets the drug rules. Aetna follows them. Two people with Aetna Better Health in two different states can have completely different GLP-1 coverage.

If your state joins BALANCE, the state must apply the model's coverage policy across both fee-for-service Medicaid and Medicaid managed care. That means it must align Aetna Better Health's managed-care policy with the model terms in that state.

The timeline

• States could choose a model start date beginning May 1, 2026
• State applications closed July 31, 2026
• Accepted states must execute an agreement with CMS by January 1, 2027

Where things stand right now

As of August 14, 2026, CMS's BALANCE page still lists participants as "N/A." No public roster of participating states has been posted.

We're telling you that plainly because we'd rather say "not published yet" than guess. If a website tells you your state is in, ask them where they got it.

What to do today

1. Find your exact state's Aetna Better Health plan — not the national page
2. Look up your state's Medicaid preferred drug list
3. Check for state BALANCE announcements from your state Medicaid agency
4. Read any notices your plan has mailed you
5. Call the number on your member card and ask two things: "Does my state cover GLP-1s for weight management?" and "Has my state joined the federal BALANCE program?"

---

What does the $50 include — and what doesn't it?

The $50 is your copay for one monthly supply of one eligible drug. It does not count toward your Part D deductible or your yearly out-of-pocket limit, Extra Help does not reduce it, coupons cannot be applied, and 60- or 90-day fills are not available.

The $50 is real. But it comes with strings, and you deserve to know them before planning your year around it.

The part that stings, said plainly

Because the Bridge sits outside Part D, that $50 a month buys you nothing toward your Part D out-of-pocket cap — $2,100 in 2026, rising to $2,400 in 2027. Twelve months of Bridge fills is $600 out of pocket that doesn't move you one dollar closer to the point where your covered Part D drugs go to $0 for the rest of the year.

And if you're on Extra Help, the subsidy that lowers your other copays does not touch this one. CMS says the full $50 applies regardless of your Part D benefit phase, and low-income cost-sharing subsidies do not apply to any part of it.

Here's what to do with that information. If the drug is for a Medicare-coverable use — type 2 diabetes, moderate-to-severe sleep apnea, noncirrhotic MASH with moderate-to-advanced fibrosis, or major cardiovascular-event risk reduction — and your Aetna plan covers it, running it through Part D may cost you less over a full year, even if the monthly number looks higher. That spending counts. It moves you toward the cap.

Do the math on twelve months, not on one.

Two smaller things people get caught by: you can't stock up with a 90-day fill, and if you're on the Zepbound KwikPen, the pen needles aren't included in the Bridge payment. Budget for them separately.

---

What happens after December 31, 2027?

The Bridge ends December 31, 2027. Nobody should promise you the same $50 access in 2028. CMS says the data it collects from the Bridge may inform a potential future implementation of BALANCE in Medicare Part D, but no post-2027 design has been announced.

We'd rather give you a straight "we don't know" than a comforting guess.

What's confirmed:

• The Bridge ends December 31, 2027
• Medicare BALANCE is not launching in 2027
• CMS says a future Part D version remains a possibility

What isn't:

• What you'd pay in 2028
• Which plans, if any, would join
• Whether the drug list stays the same
• What happens to people already on treatment
• The final 2027 Part D claims lookback period

Why Medicare can't just decide to cover this

Federal law still excludes drugs when they are used for weight loss from the normal Part D benefit. The Bridge works because CMS used demonstration authority to test a different payment method outside Part D — not because the statutory exclusion changed. A permanent nationwide Part D benefit for weight-loss-only use would require Congress to change that law.

Should you switch plans at open enrollment?

Switching among eligible Part D plan types will not improve your Bridge odds, because plans do not opt in and do not approve Bridge requests. Switching to an ineligible plan type can do the opposite: CMS says a person can lose Bridge eligibility after moving to an excluded plan type.

A future BALANCE design could make plan participation matter, but CMS has not published that design.

Our honest read: don't change a Medicare plan that's working for you based on a program that doesn't exist yet. Revisit it when CMS announces something real.

Start a folder now

If you get approved, keep these somewhere you can find them:

• Your approval letter
• Documentation of your BMI when GLP-1 therapy began
• Every pharmacy receipt
• Your diagnosis records
• Your 2026 and 2027 plan documents
• Any Part D exception decisions

One good thing about approval: it stays valid through December 31, 2027. After the first approved fill, later fills do not need a new prior authorization unless you switch to a different covered GLP-1.

Two things can still end access: filling a GLP-1 through Part D later, or moving to an ineligible plan type. You're not redoing the paperwork every three months, but you do have to stay in the Bridge lane.

---

How did we verify this Aetna GLP-1 coverage guide?

We think you should be able to check our work. Here's exactly what we opened, and what we didn't.

Provider-stated versus cross-checked

What we deliberately left out: we found no published list of states participating in BALANCE Medicaid. Rather than guess, we've told you where CMS will post it and what to ask your own state.

What stays specific to you: your exact formulary, your drug tier, your plan's prior authorization criteria, whether the medicine is medically right for you, whether your pharmacy can submit the electronic Bridge claim, your state's Medicaid policy, and whether your request gets approved.

How we built this page

We started by separating the five things people mix together — BALANCE, the Bridge, regular Part D, state Medicaid, and employer coverage. Then we traced every claim that could cost you money or time back to CMS, Aetna, FDA, or the provider's own current terms. Where those sources went quiet, we said so instead of filling the gap.

The RX Index scores providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost. This page isn't a provider ranking, though. It's a coverage-path analysis, and "your lane" is our editorial read of published rules — not an approval and not medical advice.

Why this page exists: because a request can lose weeks when it goes to the wrong payer, uses the wrong BMI date, names the wrong device, or starts the steps in the wrong order. Each of those has a different fix. Now you know which one to use.

---

Questions Aetna members keep asking

Is BALANCE an Aetna program? No. It's a CMS program. Aetna didn't create it and doesn't sell it.

Does Aetna have to opt in for me to use the Bridge? No. Medicare drug plans don't opt in to the Bridge at all. CMS's guidance states that Part D plan sponsors are not participants in it.

Can SilverScript members use the Bridge? Yes, a qualifying standalone Medicare drug plan meets the plan-type requirement. You still have to meet the prescription-purpose, drug-form, claims-history, and clinical rules.

Does Aetna approve the Bridge prior authorization? No. Aetna's own Medicare page says it does not approve these requests. Humana is CMS's central processor for Bridge prior authorizations and claims.

Does the Bridge cover Ozempic, Mounjaro, or Rybelsus? No. None is on the Bridge list. One may be covered by your Aetna Part D plan for an approved, Medicare-coverable use, depending on your formulary and coverage rules.

Does the Bridge cover every kind of Zepbound? No. KwikPen only. Single-dose vials and single-dose pens are not covered.

Do they use my current BMI or my starting BMI? CMS uses your BMI at the time GLP-1 therapy began. If you were already on therapy, use the documented initiation BMI. If you have not started, use the BMI at the time you begin therapy — not an older untreated high weight.

Does the $50 count toward my Part D out-of-pocket limit? No. It doesn't count toward your Part D deductible or yearly out-of-pocket threshold.

Does Extra Help lower the $50? No. Low-income cost-sharing subsidies don't apply to the Bridge copay.

Can I use a manufacturer coupon to lower the $50? No. Coupons and routine discount or assistance programs can't be applied to Bridge claims.

Do I need an Aetna denial before using the Bridge? No. A properly addressed Bridge claim doesn't require an ordinary Part D denial first.

What if I have type 2 diabetes? Then you are not eligible for the Bridge, even if Aetna does not cover the requested GLP-1 for diabetes. Use the Part D coverage determination and exception process.

What if I have sleep apnea? Moderate-to-severe obstructive sleep apnea puts the prescription in the Part D lane, not the Bridge.

What if I have heart disease? Heart disease alone does not automatically block the Bridge. If the drug is prescribed for weight management, you may still qualify. If it is prescribed to reduce major cardiovascular events, it belongs in Part D.

What if Part D already paid for a GLP-1 in 2026? A 2026 Part D fill for any GLP-1 on CMS's lookback list makes you ineligible for the Bridge in 2026, including a fill paid through supplemental employer or union Part D coverage.

Can I appeal a Bridge denial? There's no formal Bridge appeal process. Your prescriber can resubmit with corrected, updated, or additional information. Regular Part D denials do have appeal and exception rights.

Can an Aetna Better Health member use BALANCE? Only if that state's Medicaid program joined and the member meets the state's model rules. There's no national Aetna answer.

How long does an approval last? Through December 31, 2027. After the first approved fill, no new Bridge prior authorization is needed unless you switch to a different covered GLP-1. A later Part D GLP-1 fill or a move to an ineligible plan type can end eligibility.

What happens in 2028? Not yet decided. Don't count on $50 access continuing.

---

Still not sure which path is yours?

You've got four systems, one insurance card, and rules that live in documents written for pharmacies, prescribers, plans, states, and members. That's not your fault, and it's not your doctor's fault either.

Still not sure which GLP-1 program is right for you? Take our free matching tool — personalized in about 2 minutes.

A few questions about your plan, your drug, and why it was prescribed — then you'll see the path that fits your answers.

---

Related guides:

• What the CMS BALANCE Model is, in full
• Medicare GLP-1 Bridge eligibility, every rule
• Find My GLP-1 Path

This page is for general information. It is not medical advice and not a coverage determination. Talk with your doctor about whether a GLP-1 is right for you, and confirm coverage with your plan, Medicare, or your state Medicaid agency as applicable.